In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Global Forecast to 2027

  • Report ID:MRHC - 104414
  • Pages: 257
  • Sep 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction
    1.1. Market Definition
    1.2. Market Ecosystem
    1.3. Currency
    1.4. Key Stakeholders

2. Research Methodology
    2.1. Research Approach
    2.2. Data Collection & Validation
           2.2.1. Secondary Research
           2.2.2. Primary Research
    2.3. Market Assessment
           2.3.1. Market Size Estimation
                    2.3.1.1. Bottom-Up Approach
                    2.3.1.2. Top-Down Approach
                    2.3.1.3. Growth Forecast
           2.3.2. Market Share Analysis
    2.4. Assumptions for the Study
    2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
    4.1. Overview
    4.2. Drivers
           4.2.1. Increasing Prevalence of Acute and Chronic Infectious Diseases
           4.2.2. Increasing Funding for Research Activities
           4.2.3. Increasing Adoption of Flow Cytometry Techniques
           4.2.4. Rising Proteomics and Genomics Research Studies
    4.3. Restraints
           4.3.1. Stringent Regulations Antigen-Specific Reagents
    4.4. Opportunities
           4.4.1. Growing Demand for Protein Therapeutics and Personalized Medicines
           4.4.2. Emerging Economies
    4.5. Challenges
           4.5.1. High Cost & Unfavorable Reimbursement Scenario

5. Global In-Vitro Diagnostic Reagents Market, By Technology
    5.1. Introduction
    5.2. Immunoassay/Immunochemistry
           5.2.1. Enzyme-Linked Immunosorbent Assays (Elisa)
           5.2.2. Western Blotting
           5.2.3. Immunofluorescence
           5.2.4. Immunohistochemistry           
           5.2.5. Functional Assays
           5.2.6. Immunoprecipitation
           5.2.7. Other Technologies
    5.3. Biochemistry/Clinical Chemistry
    5.4. Molecular Diagnostics
    5.5. Microbiology
    5.6. Hematology
    5.7. Coagulation/Hemostasis
    5.8. Urinalysis
    5.9. Other Technologies

6. Global In-Vitro Diagnostic Reagents Market, By Type
    6.1. Introduction
    6.2. Antibodies
           6.2.1. Antibodies Market, By Type
                    6.2.1.1. Monoclonal
                    6.2.1.2. Polyclonal
           6.2.2. Antibodies Market, By Target
                    6.2.2.1. CD
                    6.2.2.2. TCR
                    6.2.2.3. EGFR
                    6.2.2.4. Other Targets
    6.3. Purified Proteins or Peptides
    6.4. Oligonucleotides
    6.5. Nucleic Acid Probes
    6.6. Other Reagents 

7. Global In-Vitro Diagnostic Reagents Market, By Use
    7.1. Introduction
    7.2. Clinical Use
    7.3. Research Use Only (RUO)
    7.4. Analyte-Specific Reagents (ASRs)    

8. Global In-Vitro Diagnostic Reagents Market, By End User
    8.1. Introduction
    8.2. Reference Laboratories
    8.3. IVD Manufacturers
    8.4. Academic and Research Institutes
    8.5. Hospital Laboratories    

9. Global In-Vitro Diagnostic Reagents Market, By Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. Italy
           9.3.3. France
           9.3.4. U.K.
           9.3.5. Spain           
           9.3.6. Rest of Europe (RoE)
    9.4. Asia-Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific (RoAPAC)
    9.5. Latin America
    9.6. Middle East & Africa 

10. Competitive Landscape
      10.1. Introduction
      10.2. Competitive Benchmarking
      10.3. Market Share Analysis (2019)
              10.3.1. Becton, Dickinson and Company (U.S.)
              10.3.2. Thermo Fisher Scientific, Inc. (U.S.)
              10.3.3. Merck KGAA (Germany)

11. Company Profiles
      11.1. Becton, Dickinson and Company
              11.1.1. Business Overview
              11.1.2. Financial Overview
              11.1.3. Product Portfolio
      11.2. Thermo Fisher Scientific, Inc.
              11.2.1. Business Overview
              11.2.2. Financial Overview
              11.2.3. Product Portfolio
      11.3. Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
              11.3.1. Business Overview
              11.3.2. Financial Overview
              11.3.3. Product Portfolio
      11.4. LGC Biosearch Technologies
              11.4.1. Business Overview
              11.4.2. Product Portfolio
      11.5. Biolegend, Inc.
              11.5.1. Business Overview
              11.5.2. Product Portfolio
      11.6. Inbios International, Inc.
              11.6.1. Business Overview
              11.6.2. Product Portfolio
      11.7. Lakepharma, Inc.
              11.7.1. Business Overview
              11.7.2. Product Portfolio
      11.8. Bioline Meridian Bioscience (A Part of Meridian Bioscience, Inc.)
              11.8.1. Business Overview
              11.8.2. Financial Overview
              11.8.3. Product Portfolio
      11.9. Bio-Rad Laboratories, Inc.
              11.9.1. Business Overview
              11.9.2. Financial Overview
              11.9.3. Product Portfolio
      11.10. Merck KGAA
                11.10.1. Business Overview
                11.10.2. Financial Overview
                11.10.3. Product Portfolio
      11.11. Abcam Plc.
                11.11.1. Business Overview                
                11.11.2. Financial Overview
                11.11.3. Product Portfolio
                11.11.4. Strategic Developments
                             11.11.4.1. Partnerships & Agreements
      11.12. The Binding Site Group Ltd.
                11.12.1. Business Overview
                11.12.2. Product Portfolio
      11.13. SDIX, LLC (A Subsidiary of OriGene Technologies, Inc.)
                11.13.1. Business Overview
                11.13.2. Product Portfolio
      11.14. Diaclone SaS
                11.14.1. Business Overview
                11.14.2. Product Portfolio
      11.15. Bio-Techne Corporation
                11.15.1. Business Overview
                11.15.2. Financial Overview
                11.15.3. Product Portfolio                
                11.15.4. Strategic Developments
                             11.15.4.1. Collaborations
      11.16. Agilent Technologies, Inc.
                11.16.1. Business Overview
                11.16.2. Financial Overview
                11.16.3. Product Portfolio                
                11.16.4. Strategic Developments
                             11.16.4.1. Expansions 
      11.17. Hologic, Inc.
                11.17.1. Business Overview
                11.17.2. Financial Overview
                11.17.3. Product Portfolio
      11.18. Bio-Synthesis Inc
                11.18.1. Business Overview
                11.18.2. Product Portfolio
      11.19. Raybiotech, Inc.
                11.19.1. Business Overview
                11.19.2. Product Portfolio
      11.20. Sino Biological, Inc.
                11.20.1. Business Overview
                11.20.2. Product Portfolio

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Global IVD Reagents Market Drivers: Impact Analysis (2020-2027)
Table 2 Global IVD Reagents Market Restraint: Impact Analysis (2020-2027)
Table 3 Global In-Vitro Diagnostic Reagents Market Size, By Technology, 2018-2027 ($ Million)
Table 4 Key Companies Offering IVD Reagents for Immunoassay Development
Table 5 Key Companies Offering Immunoassay Reagents for Clinical Use
Table 6 Key Companies Offering ASR for Immunoassays
Table 7 Global IVD Reagents Market Size for Immunoassay/Immunochemistry, By Application, 2018-2027 ($ Million)
Table 8 Global IVD Reagents Market Size for Immunoassay/Immunochemistry, By Country/Region, 2018-2027 ($Million)
Table 9 Global IVD Reagents Market Size for Elisa, By Country/Region, 2018-2027 ($ Million)
Table 10 Global IVD Reagents Market Size for Western Blotting, By Country/Region, 2018-2027 ($ Million)
Table 11 Global IVD Reagents Market for Immunofluorescence, By Country/Region, 2018-2027 ($ Million)
Table 12 Global IVD Reagents Market Size for Immunohistochemistry, By Country/Region, 2018-2027 ($Million)
Table 13 Global IVD Reagents Market for Functional Assays, By Country/Region, 2018-2027 ($ Million)
Table 14 Global IVD Reagents Market Size for Immunoprecipitation, By Country/Region, 2018-2027 ($ Million)
Table 15 Global IVD Reagents Market Size for Other Technologies, By Country/Region, 2018-2027 ($ Million)
Table 16 Key Companies Offering IVD Reagents for Biochemistry/Clinical Chemistry Assay Development
Table 17 Key Companies Offering Biochemistry/Clinical Chemistry IVD Reagents for Clinical Use
Table 18 Global IVD Reagents Market Size for Biochemistry/Clinical Chemistry, By Country/Region, 2018-2027 ($Million)
Table 19 Recent Molecular Diagnostic Tests Launched for Covid-19
Table 20 Key Companies Offering IVD Reagents for Molecular Diagnostics Development
Table 21 Key Companies Offering Molecular Diagnostic Reagents for Clinical Use
Table 22 Key Companies Offering ASR for Molecular Diagnostics
Table 23 Global IVD Reagents Market Size for Molecular Diagnostics, By Country/Region, 2018-2027 ($Million)
Table 24 Key Companies Offering IVD Reagents for Microbiology
Table 25 Global IVD Reparents Market Size for Microbiology, By Country/Region, 2017-2027 ($Million)
Table 26 Key Companies Offering IVD Reagents for Hematology
Table 27 Global IVD Reagents Market Size for Hematology, By Country/Region, 2018-2027 ($Million)
Table 28 Key Companies Offering IVD Reagents for Coagulation/Hemostasis
Table 29 Global IVD Reagents Market Size for Coagulation/Hemostasis, By Country/Region, 2018-2027 ($Million)
Table 30 Key Companies Offering IVD Reagents for Urinalysis
Table 31 Global IVD Reagents Market Size for Urinalysis, By Country/Region, 2018-2027 ($Million)
Table 32 Global IVD Reagents Market Size for Other Technologies, By Country/Region, 2018-2027 ($Million)
Table 33 Global In-Vitro Diagnostic Reagents Market Size, By Type, 2018-2027 ($ Million)
Table 34 Global Antibodies Market Size for IVD, By Country/Region, 2018-2027 ($ Million)
Table 35 Global Antibodies Market Size for IVD, By Type, 2018-2027 ($Million)
Table 36 Key Companies Offering Monoclonal Antibodies for IVD
Table 37 Global Monoclonal Antibodies Market Size for IVD, By Country, 2018-2027 ($ Million)
Table 38 Key Companies Offering Polyclonal Antibodies for IVD
Table 39 Global Polyclonal Antibodies Market Size for IVD, By Country/Region, 2018-2027 ($ Million)
Table 40 Global Antibodies Market Size for IVD, By Target, 2018-2027 ($Million)
Table 41 Key Companies Offering Cd Antibodies for IVD
Table 42 Global Cd Antibodies Market Size for IVD, By Country/Region, 2018-2027 ($ Million)
Table 43 Key Companies Offering TCR Antibodies for IVD
Table 44 Global TCR Antibodies Market Size for IVD, By Country/Reagents, 2018-2027 ($ Million)
Table 45 Key Companies Offering EGFR Antibodies for IVD
Table 46 Global EGFR Antibodies Market Size for IVD, By Country/Region, 2018-2027 ($ Million)
Table 47 Global Other Target Antibodies Market Size for IVD, By Country/Region, 2018-2027 ($ Million)
Table 48 Key Companies Offering Purified Proteins
Table 49 Global Purified Proteins or Peptides Market Size for IVD, By Country/Region, 2018-2027 ($Million)
Table 50 Key Companies Offering Oligonucleotides for IVD
Table 51 Global Oligonucleotides Market Size for IVD, By Country/Region, 2018-2027 ($ Million)
Table 52 Key Companies Offering Nucleic Acid Probes for IVD
Table 53 Global Nucleic Acid Probes Market Size for IVD, By Country/Region, 2018-2027 ($Million)
Table 54 Global Other Reagents Market Size for IVD, By Country/Region, 2018-2027 ($Million)
Table 55 Global In-Vitro Diagnostic Reagents Market Size, By Use, 2018-2027 ($Million)
Table 56 Global Clinical Use IVD Reagents Market Size, By Country, 2018–2027 ($Million)
Table 57 Global Research Use Only (RUO) IVD Reagents Market Size, By Country, 2018–2027 ($Million)
Table 58 Global Analyte-Specific Reagents Market Size, By Country, 2018–2027 ($Million)
Table 59 Global In-Vitro Diagnostic Reagents Market Size, By End User, 2018-2027 ($Million)
Table 60 Global IVD Reagents Market Size for Reference Laboratories, By Country, 2018–2027 ($Million)
Table 61 Global IVD Reagents Market Size for IVD Manufacturers, By Country, 2018–2027 ($Million)
Table 62 Global IVD Reagents Market Size for Academic and Research Institutes, By Country, 2018–2027 ($Million)
Table 63 Global IVD Reagents Market Size for Hospital Laboratories, By Country, 2018–2027 ($Million)
Table 64 Global In-Vitro Diagnostic Reagents Market, By Country/Region, 2018–2027 ($Million)
Table 65 North America: IVD Reagents Market Size, By Country, 2018-2027 ($Million)
Table 66 North America: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 67 North America: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 68 North America: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 69 North America: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 70 North America: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 71 North America: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 72 North America: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 73 U.S.: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 74 U.S.: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 75 U.S.: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 76 U.S.: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 77 U.S.: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 78 U.S.: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 79 U.S.: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 80 Canada: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 81 Canada: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 82 Canada: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 83 Canada: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 84 Canada: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 85 Canada: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 86 Canada: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 87 Europe: IVD Reagents Market Size, By Country, 2018-2027 ($Million)
Table 88 Europe: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 89 Europe: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 90 Europe: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 91 Europe: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 92 Europe: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 93 Europe: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 94 Europe: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 95 Germany: HIV and Aids Estimates (2018)
Table 96 Personalized Therapies Authorized in Germany (2017)
Table 97 Germany: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 98 Germany: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 99 Germany: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 100 Germany: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 101 Germany: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 102 Germany: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 103 Germany: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 104 Italy: Cancer Prevalence, 2018
Table 105 Number of Cancer Cases, (2018 Vs. 2040)
Table 106 Italy: Covid-19 Cases
Table 107 Italy: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 108 Italy: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 109 Italy: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 110 Italy: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 111 Italy: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 112 Italy: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 113 Italy: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 114 France: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 115 France: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 116 France: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 117 France: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 118 France: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 119 France: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 120 France: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 121 U.K.: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 122 U.K.: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 123 U.K.: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 124 U.K.: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 125 U.K.: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 126 U.K.: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 127 U.K.: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 128 Spain: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 129 Spain: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 130 Spain: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 131 Spain: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 132 Spain: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 133 Spain: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 134 Spain: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 135 RoE: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 136 Roe: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 137 Roe: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 138 Roe: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 139 Roe: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 140 Roe: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 141 Roe: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 142 Asia-Pacific: IVD Reagents Market Size, By Country, 2018-2027 ($Million)
Table 143 Asia-Pacific: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 144 Asia-Pacific: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 145 Asia-Pacific: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 146 Asia-Pacific: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 147 Asia-Pacific: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 148 Asia-Pacific: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 149 Asia-Pacific: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 150 Japan: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 151 Japan: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 152 Japan: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 153 Japan: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 154 Japan: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 155 Japan: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 156 Japan: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 157 China: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 158 China: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 159 China: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 160 China: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 161 China: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 162 China: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 163 China: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 164 India: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 165 India: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 166 India: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 167 India: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 168 India: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 169 India: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 170 India: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 171 RoAPAC: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 172 RoAPAC: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 173 RoAPAC: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 174 RoAPAC: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 175 RoAPAC: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 176 RoAPAC: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 177 RoAPAC: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 178 Coronavirus Cases and Deaths in Latin America (21st July 2020)
Table 179 Latin America: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 180 Latin America: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 181 Latin America: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 182 Latin America: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 183 Latin America: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 184 Latin America: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 185 Latin America: IVD Reagents Market Size, By End User, 2018-2027 ($Million)
Table 186 EDCTP Funding for Infectious Disease Diagnostics (2003-2018)
Table 187 Middle East & Africa: IVD Reagents Market Size, By Type, 2018-2027 ($Million)
Table 188 Middle East & Africa: IVD Antibodies Market Size, By Type, 2018-2027 ($Million)
Table 189 Middle East & Africa: IVD Antibodies Market Size, By Target, 2018-2027 ($Million)
Table 190 Middle East & Africa: IVD Reagents Market Size, By Technology, 2018-2027 ($Million)
Table 191 Middle East & Africa: Immunoassay/Immunochemistry IVD Reagents Market Size, By Application, 2018-2027 ($Million)
Table 192 Middle East & Africa: IVD Reagents Market Size, By Use, 2018-2027 ($Million)
Table 193 Middle East & Africa: IVD Reagents Market Size, By End User, 2018-2027 ($Million)

List of Figures

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global In-Vitro Diagnostic Reagents Market, By Type, 2020 Vs. 2027 ($Million)
Figure 8 Global In-Vitro Diagnostic Reagents Market Size, By Technology, 2020 Vs. 2027 ($Million)
Figure 9 Global In-Vitro Diagnostic Reagents Market Size, By Use, 2020 Vs. 2027 ($Million)
Figure 10 Reference Laboratories to Dominate the Global IVD Reagents Market, By End User (2019-2027)
Figure 11 In-Vitro Diagnostic Reagents Market, By Region
Figure 12 Market Dynamics
Figure 13 Share of Medical and Health R&D Expenditure of the U.S. by Type of Organization: 2017
Figure 14 Proportion of Population Aged 60 Or Over in Asia, By Region, 2016-2050
Figure 15 Global In-Vitro Diagnostic Reagents Market Size, By Technology, 2020-2027 ($Million)
Figure 16 Global In-Vitro Diagnostic Reagents Market Size, By Type, 2020-2027 ($Million)
Figure 17 Global In-Vitro Diagnostic Reagents Market Size, By Use, 2020-2027 ($Million)
Figure 18 Global In-Vitro Diagnostic Reagents Market Size, By End User, 2020-2027 ($Million)
Figure 19 Global In-Vitro Diagnostic Reagents Market, By Region, 2018–2025 ($Million)
Figure 20 France: Percentage of Older People (65 Years and Above), 2010-2050
Figure 21 In-Vitro Diagnostic Reagents: Competitive Benchmarking
Figure 22 Market Share Analysis: In-Vitro Diagnostic Reagents Industry, 2019
Figure 23 Becton, Dickinson and Company: Financial Overview (2019)
Figure 24 Thermo Fisher Scientific, Inc.: Financial Overview (2019)
Figure 25 Danaher Corporation: Financial Overview (2019)
Figure 26 Meridian Bioscience, Inc.: Financial Overview (2019)
Figure 27 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
Figure 28 Merck KGAA: Financial Overview (2019)
Figure 29 Abcam Plc: Financial Overview (2019)
Figure 30 Bio-Techne Corporation: Financial Overview (2019)
Figure 31 Agilent Technologies, Inc.: Financial Overview (2019)
Figure 32 Hologic, Inc.: Financial Overview (2019)

COVID-19

This report provides pre & post COVID-19 market estimates

Download sample here

The in-vitro diagnostic reagents market is expected to reach $77.6 billion by 2027, at a CAGR of 7% during the forecast period of 2020 to 2027. Increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies are the key factors driving the growth of the IVD reagents market. In addition, the growing demand for protein therapeutics and personalized medicines and the emerging economies are expected to create lucrative opportunities for players operating in this market.

Impact of COVID-19 on IVD Reagents Market

COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected more than 100 countries infecting more than 15,012,731 people and killing  619,150 as of 22nd July 2020 (Source: WHO). As a measure to control the spread of this disease and avoid related severe consequences, governments across the globe have announced partial or complete lockdown, which has majorly impacted many manufacturing and service industries. In this global pandemic, although many dedicated healthcare professionals work tirelessly on the frontlines to fight against this crisis, it’s equally important to minimize the spread of disease by preparing kits for early diagnosis. Testing is one of the greatest tools in understanding and managing the coronavirus pandemic. In response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling various assays & kits prepared using the IVD reagents. These simple test kits are based either on detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or detection, in blood or serum, of human antibodies generated in response to infection. Thus, the pandemic has increased the adoption of IVD reagents for kits and assay preparation using immunoassay and molecular diagnostics technology.

                                                         Click here to: Get Free Sample Pages of this Report

Increase in the funding for research activities is propelling the growth of the  IVD reagents market

The R&D activities in academic institutes and government research institutes have significantly increased in the last 2-3 decades with rising funding from various government organizations driven by rising health care concern globally, complexity of clinical trials, and higher failure of drugs in earlier phase studies. In the U.S., the government R&D spending agencies such as Department of Defense (DOD), National Institutes of Health (NIH), Department of Energy (DOE), and National Aeronautics and Space Administration (NASA) account for 90% of the total R&D investments, globally. The National Institutes of Health (NIH) is the largest source of funding for basic and applied research in the world, providing approximately 84% of NIH funds to universities, medical schools, and other research institutes. In addition to this, according to WHO, it has been projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide with number of people with diabetes will increase by 2.5-fold in 2020.

Thus, the increased complexities and mortality rate due to diseases such as COVID-19, cardiovascular diseases, diabetes, cancers, and chronic respiratory diseases fuels the funding for research, ultimately driving the growth of the IVD reagents market.

Key Findings in the Global IVD Reagents Market Study:

Immunoassay/immunochemistry segment to dominate the IVD reagents market in 2020

The immunoassay/immunochemistry segment is estimated to dominate the IVD reagents market in 2020. Advantages offered by the segment like inherent specificity, high-throughput, high sensitivity, and low cost are driving the growth of this technology segment. Further, the increasing use of immunoassays in POC & infectious disease testing, development of novel tests, and rising demand for immunoassay-based tests are driving the growth of this market.

Antibodies segment to dominate the IVD reagents market in 2020  

The antibodies segment is estimated to dominate the overall IVD reagents market in 2020. The large share of this segment is mainly attributed to the widespread application of antibodies in medicine for the purpose of research, diagnosis, drug & IVD development, and disease treatment. In addition, the increasing proteomics & genomics-based research, funding for R&D, and rising need for disease specific biomarkers expands the use of antibodies in the IVD industry.

Asia Pacific: The fastest growing market

At regional level, IVD reagents market is estimated to be dominated by the North America in 2020, while, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of Asia Pacific IVD reagents market are rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, rising need to manage growing burden of infectious diseases, growing accessibility to healthcare services & advanced products, growing income levels of middle-class population, and increasing number of hospitals and clinics.

Key Players

The report includes competitive landscape based on the extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by the leading market players in the industry over the past 4 years (2017-2020). The key players profiled in the global IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China).

Scope of the Report:

IVD Reagents Market, by Technology

  • Immunoassay/Immunochemistry
    • Enzyme-Linked Immunosorbent Assays (Elisa)
    • Western Blotting
    • Immunofluorescence
    • Immunohistochemistry
    • Functional Assays
    • Immunoprecipitation
    • Other Technologies
  • Biochemistry/Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation/Hemostatis
  • Urinalysis
  • Other Technologies
    (Other Technologies comprises of hybridization and loop-mediated isothermal amplification among others)

IVD Reagents Market, by Type

  • Antibodies
    • Antibodies Market, By Type
      • Monoclonal
      • Polyclonal
    • Antibodies Market, By Target
      • CD
      • TCR
      • EGFR
      • Other Targets
  • Oligonucleotides
  • Nucleic Acid Probes
  • Purified Proteins or Peptides
  • Other Reagents
    (Other reagents include Blocking Agents, Detergents, Surfactants, Wetting Agents, Buffers, Stabilizers, Purified Water, Dyes, Standards & Controls, Enzymes, Cell Culture Reagents, and Anti-coagulants)

IVD Reagents Market, by Use

  • Research Use Only
  • Analyte Specific Reagents
  • Clinical Use

IVD Reagents Market, by End User

  • IVD Manufacturers
  • Reference Laboratories
  • Academic and Research Institutes
  • Hospital Laboratories

IVD Reagents Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

The IVD reagents market covers the market size & forecasts of the IVD reagents like the oligonucleotides, antibodies, nucleic acid probes, purifies proteins & peptides, and other reagents. The IVD reagents market studied in this report involves the revenue analysis of various segments and sub segments of IVD reagents at regional and country level.
Based on the type, the antibodies segment is estimated to command the largest share of the overall IVD reagents market in 2020. However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period.
Based on the technology, the immunoassay/immunochemistry segment is projected to create more traction owing to the advantages offered by the segment like the inherent specificity, high-throughput, high sensitivity, and low cost are driving the growth of this technology segment. Further, the increasing use of immunoassays in POC & infectious disease testing, development of novel tests, and rising demand for immunoassay-based tests are the other key factors driving the growth of this market.
Increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increased funding for research activities, and rising proteomics and genomics research studies are the key drivers of this market. However, the growing demand for protein therapeutics and personalized medicines and emerging economies are expected to create lucrative opportunities for players operating in this market.
The key players operating in the global IVD reagents market are Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), LGC Biosearch Technologies (U.K.), BioLegend, Inc. (U.S.), InBios International, Inc. (U.S.), LakePharma, Inc. (U.S.), Bioline (U.K.), Abcam plc (U.K.), The Binding Site Group Ltd.(U.K.), SDIX, LLC (U.S.), DIACLONE SAS (France), Bio-Techne Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Hologic Inc. (U.S.), Bio-Synthesis Inc. (U.S.), RayBiotech, Inc. (U.S.), and Sino Biological Inc. (China) among others
The emerging countries from Asia and Latin America are projected to offer significant growth opportunities for the vendors operating in this market due to rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, growing infectious diseases, and growing accessibility to healthcare services & advanced products.
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Medical Technologies
Download Free Sample